Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of the management of high-risk population. Issue 3 (13th August 2020)

• Record Type: Journal Article
• Authors: Wang, Yilong; Han, Shangrong; Qin, Haiqiang; Zheng, Huaguang; Jiang, Bin; Cao, Yong; Gao, Yuan; Guan, Ling; Jia, Qian; Jiang, Yong; Jiao, Yuming; Li, Shuya; Li, Yapeng; Li, Zixiao; Liu, Wei; Ru, Xiaojuan; Sun, Dongling; Sun, Haixin; Wang, Penglian; Wang, Tingting; Zong, Lixia; Guo, Lei; Xie, Xuewei; Xu, Yuming; Xu, Yuyuan; Yang, Xiaomeng; Yang, Yingying; Zhou, Mengyuan; Wang, Wenzhi
• Other Names: author non-byline.; Wang Yongjun author non-byline.; Zhao Jizong author non-byline.; Dong Qiang author non-byline.; Xu Anding author non-byline.; Chen Kangning author non-byline.; Ge Junbo author non-byline.; Li Guo Li He author non-byline.; Hu Bo author non-byline.; Huo Yong author non-byline.; Ji Linong author non-byline.; Ji Xunming author non-byline.; Li Tielin author non-byline.; Liu Liping author non-byline.; Luo Benyan author non-byline.; Miao Zhongrong author non-byline.; Niu Xiaoyuan author non-byline.; Peng Bin author non-byline.; Su Dingfeng author non-byline.; Tang Beisha author non-byline.; Wang Chen author non-byline.; Wang Ning author non-byline.; Wang Shuo author non-byline.; Wang Wei author non-byline.; Wang Xin author non-byline.; Wang Yilong author non-byline.; Wu Shizheng author non-byline.; Xie Peng author non-byline.; Xu Yuming author non-byline.; Xu Yun author non-byline.; Yang Yi author non-byline.; Zeng Jinsheng author non-byline.; Zhang Chaodong author non-byline.; Zhang Tong author non-byline.; Zhang Zhuo author non-byline.; Zhao Gang author non-byline.; Zhao Xingquan author non-byline.;
• Is Part Of: Stroke and vascular neurology. Volume 5:Issue 3(2020)
• Page Start: 270
• Page End: 278
• Publication Date: 2020-08-13
• Subjects: stroke -- atherosclerosis -- blood pressure -- platelets; Cerebrovascular disease -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; 616.81005
• DOI: 10.1136/svn-2020-000385
• Languages: English
• ISSNs: 2059-8688

Abstract

Abstract : Aim: Cerebrovascular disease is the leading cause of death and disability in China, causing a huge burden among patients and their families. Hence, stroke prevention is critical, especially in the high-risk population. Here, we present the evidence-based guideline suitable for the Chinese population. Methods: Literature search of PubMed and Cochrane library (from January 1964 to June 2019) was done. After thorough discussion among the writing group members, recommendations were listed and summarised. This guideline was reviewed and discussed by the fellow writing committees of the Chinese Stroke Association's Stroke. Results: This evidence-based guideline was written in three parts: controlling the risk factors of stroke, utilisation of antiplatelet agents and assessing the risks of first-ever stroke. All recommendations were listed along with the recommending classes and levels of evidence. Conclusions: This guideline provides recommendations for primary prevention of cerebrovascular disease among high-risk population in China. Controlling related risk factors, appropriately using antiplatelet agents, assessing the risk of developing first-ever stroke should help reduce the rate of cerebrovascular disease in China.